{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:12:46Z","timestamp":1790827966426,"version":"4.1.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institute of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heart and Stroke Foundation of Canada"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cjca.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T02:05:58Z","timestamp":1555034758000},"page":"1208-1219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Cardiorenal Syndrome and Heart Failure\u2014Challenges and Opportunities"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-026X","authenticated-orcid":false,"given":"Haran","family":"Yogasundaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branko","family":"Braam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.04.002_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure","volume":"60","author":"Ronco","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.04.002_bib3","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/ehu320","article-title":"Terminology and definition of changes renal function in heart failure","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.04.002_bib4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ndt\/gfq066","article-title":"Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"Bagshaw","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2019.04.002_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ndt\/gfn445","article-title":"Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study","volume":"24","author":"Campbell","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2019.04.002_bib6","first-page":"1342","article-title":"2017 Comprehensive update of the Canadian Cardiovascular Society Guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib7","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.04.002_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/eurheartj\/ehi020","article-title":"The severe cardiorenal syndrome: \u201cGuyton revisited.\u201d","volume":"26","author":"Bongartz","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.04.002_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000349966","article-title":"Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"McCullough","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib10","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.04.002_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2013.250","article-title":"Cardiorenal syndrome--current understanding and future perspectives","volume":"10","author":"Braam","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib13","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.cjca.2019.04.002_bib14","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.cjca.2019.04.002_bib15","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.cjca.2019.04.002_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.04.002_bib17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/eurjhf\/hfr087","article-title":"Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial","volume":"13","author":"Maisel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2215\/CJN.06140710","article-title":"Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward","volume":"6","author":"Alvelos","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib19","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jacc.2016.06.055","article-title":"Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study","volume":"68","author":"Maisel","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jchf.2013.05.007","article-title":"Tubular damage and worsening renal function in chronic heart failure","volume":"1","author":"Damman","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/eurjhf\/hfr102","article-title":"Kidney injury molecule-1 and N-acetyl-beta-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome","volume":"13","author":"Jungbauer","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/nep.12632","article-title":"N-acteyl-ss-D-glucosaminidase and kidney injury molecule-1: new predictors for long-term progression of chronic kidney disease in patients with heart failure","volume":"21","author":"Jungbauer","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.cjca.2019.04.002_bib23","first-page":"1325","article-title":"Prognostic effect of renal function in ambulatory patients with heart failure and reduced ejection fraction: the kidney is a marker of cardiac function","volume":"34","author":"Mascarenhas","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneph.2012.279","article-title":"Cardiorenal syndrome: pathophysiology and potential targets for clinical management","volume":"9","author":"Hatamizadeh","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jchf.2016.05.009","article-title":"Intrarenal venous flow: a window into the congestive kidney failure phenotype of heart failure?","volume":"4","author":"Tang","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease","volume":"53","author":"Damman","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1152\/ajplegacy.1956.185.2.430","article-title":"Micropuncture study of pressures in proximal tubules and peritubular capillaries of the rat kidney and their relation to ureteral and renal venous pressures","volume":"185","author":"Gottschalk","year":"1956","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10741-011-9246-2","article-title":"Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure","volume":"17","author":"Braam","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2019.04.002_bib31","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jchf.2016.03.016","article-title":"Clinical implications of intrarenal hemodynamic evaluation by Doppler ultrasonography in heart failure","volume":"4","author":"Iida","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ki.1982.14","article-title":"Plasma aldosterone concentrations in chronic renal disease","volume":"21","author":"Hene","year":"1982","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ki.1973.112","article-title":"Intrarenal distribution of blood flow and renin release during renal venous pressure elevation","volume":"4","author":"Kishimoto","year":"1973","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2013.07.010","article-title":"Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure","volume":"63","author":"Mori","year":"2013","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib35","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1097\/01.ASN.0000086472.65806.73","article-title":"Aldosterone in chronic kidney and cardiac disease","volume":"14","author":"Hostetter","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib36","first-page":"E763","article-title":"Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure","volume":"262","author":"Reid","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCHEARTFAILURE.110.960831","article-title":"CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess","volume":"4","author":"Chu","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.hlc.2016.02.022","article-title":"Role of renal oxidative stress in the pathogenesis of the cardiorenal syndrome","volume":"25","author":"Giam","year":"2016","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cjca.2019.04.002_bib40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-2828(03)00145-7","article-title":"NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy","volume":"35","author":"Nakagami","year":"2003","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib41","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0735-1097(03)00471-6","article-title":"Increased myocardial NADPH oxidase activity in human heart failure","volume":"41","author":"Heymes","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib42","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib43","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","article-title":"Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure","volume":"340","author":"Ligtenberg","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.ASN.0000045049.72965.B7","article-title":"Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure","volume":"14","author":"Klein","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib45","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1523-1755.2005.09911.x","article-title":"The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease","author":"Remuzzi","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.cjca.2019.04.002_bib46","doi-asserted-by":"crossref","first-page":"F812","DOI":"10.1152\/ajprenal.00655.2013","article-title":"Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity","volume":"306","author":"Mori","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib47","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2019.04.002_bib48","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib49","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1681\/ASN.2008040402","article-title":"Sympathetic activation in chronic renal failure","volume":"20","author":"Schlaich","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","article-title":"Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity","volume":"73","author":"Hasking","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.04.002_bib51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cardfail.2009.12.022","article-title":"The sympathorenal axis in hypertension and heart failure","volume":"16","author":"Goldsmith","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1681\/ASN.V131117","article-title":"Cardiac beta-adrenoceptor desensitization due to increased beta-adrenoceptor kinase activity in chronic uremia","volume":"13","author":"Leineweber","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib53","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/eurheartj\/ehi184","article-title":"Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure","volume":"26","author":"Petersson","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.04.002_bib54","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1388-9842(03)00163-6","article-title":"Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)","volume":"5","author":"Cohn","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib55","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.jacc.2013.10.073","article-title":"Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction","volume":"63","author":"Schirmer","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/07853890.2017.1282168","article-title":"Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence","volume":"49","author":"Nammas","year":"2017","journal-title":"Ann Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib57","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A\u00a0controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib58","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/ejhf.921","article-title":"The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology","volume":"19","author":"van Bilsen","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib59","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1523-1755.2001.00936.x","article-title":"Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers","volume":"60","author":"Amann","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib60","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.ki.5001835","article-title":"Beta blockers in the management of chronic kidney disease","volume":"70","author":"Bakris","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2017.01.047","article-title":"Effect of renal denervation on kidney function in patients with chronic kidney disease","volume":"232","author":"Hering","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib62","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/00004872-200309000-00021","article-title":"Moxonidine treatment of hypertensive patients with advanced renal failure","volume":"21","author":"Vonend","year":"2003","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.cjca.2019.04.002_bib63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2008.11.014","article-title":"Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modality","volume":"602","author":"Rastmanesh","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cjca.2019.04.002_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2008.07.013","article-title":"Increased expression of SOCS3 in monocytes and SOCS1 in lymphocytes correlates with progressive loss of renal function and cardiovascular risk factors in chronic kidney disease","volume":"593","author":"Rastmanesh","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cjca.2019.04.002_bib65","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib66","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjca.2019.04.002_bib67","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10741-011-9261-3","article-title":"Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome","volume":"17","author":"Colombo","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2019.04.002_bib69","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00787.2016","article-title":"Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins","volume":"313","author":"Guo","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib70","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.cjca.2019.04.002_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10741-016-9534-y","article-title":"Cellular apoptosis in the cardiorenal axis","volume":"21","author":"Virzi","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2019.04.002_bib72","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","article-title":"End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?","volume":"59","author":"Arici","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib73","doi-asserted-by":"crossref","first-page":"e99495","DOI":"10.1371\/journal.pone.0099495","article-title":"Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology","volume":"9","author":"Putko","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2019.04.002_bib74","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib75","doi-asserted-by":"crossref","first-page":"e009098","DOI":"10.1161\/JAHA.118.009098","article-title":"Elevated inflammatory plasma biomarkers in patients with Fabry disease: a critical link to heart failure with preserved ejection fraction","volume":"7","author":"Yogasundaram","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2019.04.002_bib76","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1681\/ASN.V591697","article-title":"Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency","volume":"5","author":"Ward","year":"1995","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib77","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.04.002_bib78","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/01.CIR.0000041431.57222.AF","article-title":"Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase","volume":"106","author":"Landmesser","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.04.002_bib79","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib80","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib81","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","article-title":"Advanced oxidation protein products as a novel marker of oxidative stress in uremia","volume":"49","author":"Witko-Sarsat","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib82","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.RES.83.7.743","article-title":"Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats","volume":"83","author":"Katoh","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2019.04.002_bib83","doi-asserted-by":"crossref","first-page":"R815","DOI":"10.1152\/ajpregu.00727.2009","article-title":"Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney disease","volume":"298","author":"Bongartz","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib84","doi-asserted-by":"crossref","first-page":"H2037","DOI":"10.1152\/ajpheart.00400.2010","article-title":"The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction","volume":"299","author":"Bongartz","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib85","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib86","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/ndt\/gfp393","article-title":"Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis","volume":"25","author":"Kane","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2019.04.002_bib87","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.CIR.102.14.1671","article-title":"Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease","volume":"102","author":"Watson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.04.002_bib88","first-page":"506","article-title":"Hypertension Canada\u2019s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children","volume":"34","author":"Nerenberg","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib89","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/eurheartj\/ehr056","article-title":"Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome","volume":"32","author":"Messerli","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.04.002_bib90","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1046\/j.1523-1755.2001.00953.x","article-title":"Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography","volume":"60","author":"Conlon","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2019.04.002_bib91","article-title":"Resistant hypertension from renal artery stenosis leading to heart failure with preserved ejection fraction","volume":"6","author":"Alyamani","year":"2018","journal-title":"J\u00a0Investig Med High Impact Case Rep"},{"key":"10.1016\/j.cjca.2019.04.002_bib92","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S1051-0443(07)61948-4","article-title":"Chronic renal ischemia: pathophysiologic mechanisms of cardiovascular and renal disease","volume":"13","author":"Rundback","year":"2002","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib93","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1681\/ASN.2005010043","article-title":"Left ventricular morphology and function in patients with atherosclerotic renovascular disease","volume":"16","author":"Wright","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1310753","article-title":"Stenting and medical therapy for atherosclerotic renal-artery stenosis","volume":"370","author":"Cooper","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"840-8","key":"10.1016\/j.cjca.2019.04.002_bib95","first-page":"w150","article-title":"Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial","volume":"150","author":"Bax","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib96","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","article-title":"Revascularization vs medical therapy for renal-artery stenosis","volume":"361","author":"Wheatley","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib97","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib98","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib99","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1001\/jamainternmed.2018.4673","article-title":"Reduced salt intake for heart failure: a systematic review","volume":"178","author":"Mahtani","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib100","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.158.10.1108","article-title":"NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics","volume":"158","author":"Heerdink","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjcard.2005.07.016","article-title":"Pathophysiologic targets in the early phase of acute heart failure syndromes","volume":"96","author":"Gheorghiade","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?","volume":"47","author":"Schrier","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib103","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib104","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2012.12.050","article-title":"The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure","volume":"61","author":"van der Meer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib105","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: clinical characteristics and prognostic significance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.04.002_bib106","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ahj.2015.05.003","article-title":"Diuretic response in acute heart failure-an analysis from ASCEND-HF","volume":"170","author":"ter Maaten","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2019.04.002_bib108","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial","volume":"9","author":"Hasselblad","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib109","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1681\/ASN.2016111178","article-title":"Compensatory distal reabsorption drives diuretic resistance in human heart failure","volume":"28","author":"Rao","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib110","first-page":"S57","article-title":"Sodium and water retention in heart failure: pathogenesis and treatment","volume":"59","author":"Martin","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.cjca.2019.04.002_bib111","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00392-011-0335-y","article-title":"Sympatho-renal axis in chronic disease","volume":"100","author":"Sobotka","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0140-6736(90)90148-X","article-title":"Metolazone in treatment of severe refractory congestive cardiac failure","volume":"335","author":"Kiyingi","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2019.04.002_bib113","doi-asserted-by":"crossref","first-page":"e009149","DOI":"10.1161\/JAHA.118.009149","article-title":"Outcomes associated with a strategy of adjuvant metolazone or high-dose loop diuretics in acute decompensated heart failure: a propensity analysis","volume":"7","author":"Brisco-Bacik","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2019.04.002_bib114","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib115","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2019.04.002_bib116","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2019.04.002_bib117","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","article-title":"Abdominal contributions to cardiorenal dysfunction in congestive heart failure","volume":"62","author":"Verbrugge","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib118","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jacc.2007.04.070","article-title":"The UNLOAD trial: a \u201cnephrologic\u201d standpoint","volume":"50","author":"Kazory","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib119","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchf.2015.08.005","article-title":"Aquapheresis vs intravenous diuretics and hospitalizations for heart failure","volume":"4","author":"Costanzo","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib121","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2017.03.528","article-title":"Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research","volume":"69","author":"Costanzo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib122","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","article-title":"Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine","volume":"12","author":"Gheorghiade","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib123","doi-asserted-by":"crossref","first-page":"F932","DOI":"10.1152\/ajprenal.00200.2006","article-title":"Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors","volume":"291","author":"Jie","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib124","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/eurjhf\/hfq167","article-title":"The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival","volume":"13","author":"Scrutinio","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10741-008-9089-7","article-title":"The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes","volume":"13","author":"Tang","year":"2008","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2019.04.002_bib126","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","article-title":"Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure","volume":"1","author":"Cleland","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib127","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.amjcard.2007.07.067","article-title":"Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry)","volume":"101","author":"Young","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib128","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ejhf.139","article-title":"High prevalence of iron deficiency in patients with acute decompensated heart failure","volume":"16","author":"Cohen-Solal","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib129","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.ASN.0000018409.45834.FA","article-title":"Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study","volume":"13","author":"McClellan","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2019.04.002_bib130","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.04.002_bib131","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.04.002_bib132","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib133","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfs017","article-title":"Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis","volume":"14","author":"Avni","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2019.04.002_bib134","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2019.04.002_bib135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jacc.2008.10.046","article-title":"Anemia: the point of convergence or divergence for kidney disease and heart failure?","volume":"53","author":"Kazory","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib136","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.002_bib137","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.107.698514","article-title":"Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia","volume":"117","author":"Ghali","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.04.002_bib138","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1159\/000450559","article-title":"Improved left ventricular structure and function after successful kidney transplantation","volume":"41","author":"Hewing","year":"2016","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.cjca.2019.04.002_bib139","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2004.11.061","article-title":"Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease","volume":"45","author":"Wali","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib140","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1503\/cmaj.051291","article-title":"Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation","volume":"173","author":"Knoll","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2019.04.002_bib141","doi-asserted-by":"crossref","first-page":"e13417","DOI":"10.1111\/ctr.13417","article-title":"Cardiorenal syndrome in renal transplant recipients\u2014it\u2019s the fistula at fault: a case series","volume":"32","author":"Samarendra","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cjca.2019.04.002_bib142","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5301\/jva.5000154","article-title":"Acute cardiorenal syndrome by high flow arteriovenous fistula after kidney transplantation","volume":"14","author":"Nickel","year":"2013","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.cjca.2019.04.002_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2019.04.002_bib144","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.ackd.2018.08.012","article-title":"Advanced heart failure therapies and cardiorenal syndrome","volume":"25","author":"Cowger","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.cjca.2019.04.002_bib145","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/ajt.12522","article-title":"Heart and combined heart-kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure","volume":"14","author":"Schaffer","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cjca.2019.04.002_bib146","doi-asserted-by":"crossref","first-page":"e008664","DOI":"10.1161\/JAHA.118.008664","article-title":"Implantable ventricular assist device use and outcomes in people with end-stage renal disease","volume":"7","author":"Walther Carl","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2019.04.002_bib147","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.healun.2013.09.001","article-title":"Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant","volume":"32","author":"Kirklin","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2019.04.002_bib148","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.002_bib149","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","article-title":"Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study","volume":"109","author":"McAlister","year":"2004","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19302612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19302612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:41:19Z","timestamp":1760107279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19302612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":149,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0828282X19302612"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.04.002","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiorenal Syndrome and Heart Failure\u2014Challenges and Opportunities","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}